Publications by authors named "Marialuisa Mastrandrea"

Objectives: to assess the performance of a combined first-trimester screening for trisomy 21 in an unselected Italian population referred to a specialized private center for prenatal medicine.

Methods: a retrospective validation of first-trimester screening algorithms [risk calculation based on maternal age and nuchal translucency (NT) alone, maternal age and serum parameters (free β-hCG and PAPP-A) alone and a combination of both] for fetal aneuploidies evaluated in an unselected Italian population at Artemisia Fetal-Maternal Medical Centre in Rome. All measurements were performed between 11(+0) and 13(+6) weeks of gestation, between April 2007 and December 2008.

View Article and Find Full Text PDF

Objectives: To validate new references charts and equations for fetal biometry in an Italian unselected population.

Methods: A cross-sectional study involving 4896 women with singleton viable pregnancies, at Artemisia Fetal Maternal Medical Centre between May 2009 and December 2009. Each woman was scanned only once, between 14+0 and 40+0 weeks of gestation.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Marialuisa Mastrandrea"

  • Marialuisa Mastrandrea's research primarily focuses on prenatal diagnosis and screening techniques, aiming to enhance the accuracy and effectiveness of detecting fetal abnormalities through innovative methodologies.
  • Her studies include the introduction of Next Generation Sequencing (NGPD) for genomic amnio and villous sampling, which promises improved diagnostic capabilities in prenatal genetics.
  • Additionally, her work features a retrospective analysis of first-trimester combined screening for trisomy 21, evaluating its performance in an unselected Italian population, and the establishment of reference intervals for fetal biometry, contributing significant data for clinical practice in prenatal medicine.